The team of Muriel Amblard and Anthony Martin publishes in Nature Cancer!
PROTACs-PI3Kγ open a new pathway for targeted treatment of acute myeloid leukemia (AML) Acute myeloid leukemia (AML) is the most common leukemia in adults. Recent medical advances have achieved up to 50% 5-year survival rates. However, this rate still needs improvement, especially for individuals aged 60 and over, whose 5-year survival rate is only 10%, […]